This study is testing an intervention called OPTIMISE to help cancer patients better manage their health conditions and improve communication between their cancer doctors (oncologists) and primary care doctors. You may be able to join if you are an adult (18 years or older) recently diagnosed with early-stage breast, gastrointestinal (GI), or hematologic (blood) cancer, and are also managing other chronic health conditions like diabetes or high blood pressure. The study wants to see if OPTIMISE helps you feel more involved in your own care and improves how you manage your health, measured at 4 months after you start treatment. The study is currently recruiting 340 participants, but its overall status is unclear.

Study design

This is a randomized controlled trial involving 300 medically underserved patients with breast, GI, or hematological cancer and other health conditions. Participants will be split into two groups: one receiving usual medical care and the other receiving the OPTIMISE intervention.

What's involved

You will complete surveys at the start of your cancer treatment, at 2 and 4 months after treatment begins, when you receive your Survivorship Care Plan (SCP), and then at 3, 6, and 12 months after receiving your SCP.

Compensation

Not stated in the trial record.

Follow-up

You will be followed for at least 12 months after receiving your Survivorship Care Plan (SCP) to complete surveys.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.